Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Matinas Biopharma Hl (NY: MTNB ) 0.1666 -0.0023 (-1.36%) Official Closing Price Updated: 8:00 PM EDT, Jul 11, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Matinas Biopharma Hl < Previous 1 2 3 Next > 12 Health Care Stocks Moving In Thursday's Pre-Market Session May 11, 2023 Via Benzinga Why Muscle Maker Shares Are Trading Higher By 24%; Here Are 20 Stocks Moving Premarket May 11, 2023 Gainers Audacy, Inc. (NYSE: AUD) gained 75.8% to $0.2337 in pre-market trading after gaining around 16% on Wednesday. The company posted upbeat quarterly sales. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday May 11, 2023 It's time for another dive into the biggest pre-market stock movers as we check out the latest news traders need to know about on Thursday! Via InvestorPlace Recap: Matinas BioPharma Hldgs Q1 Earnings May 10, 2023 Via Benzinga Earnings Outlook For Matinas BioPharma Hldgs March 14, 2023 Via Benzinga Matinas BioPharma: Q2 Earnings Insights August 11, 2022 Matinas BioPharma Hldgs (AMEX:MTNB) reported its Q2 earnings results on Thursday, August 11, 2022 at 06:15 AM. Here's what investors need to know about the announcement. Via Benzinga Earnings Scheduled For August 11, 2022 August 11, 2022 Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million. Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session May 10, 2023 Via Benzinga 7 Small-Cap Biotech Stocks with Massive Potential April 27, 2023 Although small-cap biotech stocks present high risks, if they hit one out of the park, the rewards can be astronomical. Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's Intraday Session April 19, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session April 19, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session March 14, 2023 Via Benzinga Earnings Scheduled For March 15, 2023 March 15, 2023 Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million. Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session March 09, 2023 Via Benzinga Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday October 24, 2022 Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Friday. Via Benzinga Matinas BioPharma Hldgs: Q1 Earnings Insights May 12, 2022 Matinas BioPharma Hldgs (AMEX:MTNB) reported its Q1 earnings results on Thursday, May 12, 2022 at 06:15 AM. Here's what investors need to know about the announcement. Via Benzinga The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More May 12, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga A Preview Of Matinas BioPharma Hldgs's Earnings May 11, 2022 Matinas BioPharma Hldgs (AMEX:MTNB) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that... Via Benzinga HC Wainwright Reiterates Buy Rating On BioNTech, While Lowers Price Target April 12, 2022 HC Wainwright has reiterated its Buy rating on BioNTech SE (NASDAQ: BNTX) while reducing the price tar Via Benzinga BioNTech And Matinas BioPharma Announce Exclusive Research Collaboration To Evaluate Novel Delivery Technology For mRNA-based Vaccines April 11, 2022 This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Via Benzinga Matinas BioPharma Inks mRNA-Based Vaccine Pact With BioNTech April 11, 2022 BioNTech SE (NASDAQ: BNTX) and Matinas BioPharma Holdings Inc (NYSE: MTNB) have Via Benzinga Here's Why Matinas BioPharma Shares Are Rising April 11, 2022 Matinas BioPharma Holdings Inc (NASDAQ: MTNB) shares are trading higher by 10.4% at $0.86 after the company and BioNTech announced an exclusive research collaboration to... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday March 25, 2022 Good morning, trader! Get ready for one more busy day of investing today with the biggest pre-market stock movers for Friday! Via InvestorPlace 34 Stocks Moving in Friday's Pre-Market Session March 25, 2022 Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) rose 40.5% to $2.22 in pre-market trading after the company reported better-than-expected Q4 sales results and reaffirmed FY22... Via Benzinga Matinas BioPharma Updates — Q4 2021 Earnings And Conference Call Recap March 21, 2022 This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Via Benzinga The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout March 08, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative... Via Benzinga Matinas BioPharma: Q4 Earnings Insights March 08, 2022 Matinas BioPharma Hldgs (AMEX:MTNB) reported its Q4 earnings results on Tuesday, March 8, 2022 at 06:15 AM. Here's what investors need to know about the announcement.... Via Benzinga Earnings Scheduled For March 8, 2022 March 08, 2022 Companies Reporting Before The Bell • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million. •... Via Benzinga Earnings Preview For Matinas BioPharma Hldgs March 07, 2022 Matinas BioPharma Hldgs (AMEX:MTNB) is set to give its latest quarterly earnings report on Tuesday, 2022-03-08. Here's what investors need to know before the announcement.... Via Benzinga The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg March 06, 2022 Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.